The fibromyalgia syndrome: A consensus report on fibromyalgia and disability

Journal of Rheumatology

Volumn 23, Issue 3, 1996, Pages 534-539

  Wolfe, Frederick ^a   Allen, Murray ^b   Bennett, Robert M ^c   Bombardier, Claire ^d   Broadhurst, Norman ^e   Cameron, Robert S ^f   Carette, Simon ^g   Chalmers, Andrew ^h   Cohen, Milton ⁱ   Crook, Joan ^j   Ehrlich, George E ^b   Fam, Adel ^k   Gillies, Jean ^l   Goldenberg, Don ^b   Hendriksson, K G ^m   Janda, Vladimir ⁿ   Littlejohn, Geoffrey ^o   McCain, Glenn A ^p   Mease, Phillip ^q   Moldofsky, Harvey ^r   Olin, Robert ^s   Pontinen, Pekka J ^t   Puttick, Michael ^u   Raspe, Hemer ^v   Reilly, Paul A ^w   Reynolds, Jack ^r   Rice, John R ^x   Romano, Thomas J ^y   Russell, Tony ^z   Jon Russell, I ^aa   Silverman, Stuart ^b   Simmb, Robert ^ab   Smythe, Hugh ^d   Tunks, Eldon ^ac   Uslan, Don ^ad   Yunus, Muhammad B ^ae   more..

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b Oregon Health Sciences University ^*

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e FLINDERS MEDICAL CENTRE   (Australia)

^f London Life Insurance Co   (Canada)

^g UNIVERSITÉ LAVAL   (Canada)

^h VANCOUVER GENERAL HOSPITAL   (Canada)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j MCMASTER UNIVERSITY   (Canada)

^k SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^l ST PAUL S HOSPITAL   (Canada)

^m LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

ⁿ CHARLES UNIVERSITY   (Czech Republic)

^o MONASH MEDICAL CENTRE   (Australia)

^p National Social Insurance Hospital   (United States)

^q Tampere University   (United States)

^r UNIVERSITY HEALTH NETWORK   (Canada)

^s National Social Insurance Hospital   (Sweden)

^t TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^u UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^v UNIVERSITY OF LÜBECK   (Germany)

^w FRIMLEY PARK HOSPITAL   (United Kingdom)

^x DUKE UNIVERSITY   (United States)

^y Professional Center III   (United States)

^z UNIVERSITY OF ALBERTA   (Canada)

^aa UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^ab BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ac HAMILTON HEALTH SCIENCES   (Canada)

^ad Center for Comprehensive Care   (United States)

^ae UNIVERSITY OF ILLINOIS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANXIOLYTIC AGENT; CORTICOSTEROID; CYCLOBENZAPRINE; NONSTEROID ANTIINFLAMMATORY AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; COMPLICATION; DIAGNOSIS; DISABILITY; FIBROMYALGIA; HUMAN; NOCICEPTION; PRIORITY JOURNAL; REVIEW;

BRITISH COLUMBIA; DISABILITY EVALUATION; FIBROMYALGIA; HUMANS;

EID: 0029880125     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Moldofsky H, Scarisbrick P, England R, Smythe HA: Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975;37:341-51.
2. Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72
3. Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151-71.
4. Smythe HA, Moldofsky H. Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis 1977;28:928-31.
5. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
6. Bennett RM: Disabling fibromyalgia: Appearance versus reality (editorial). J Rheumatol 1993;11:1821-4.
7. Bruusgaard D, Evensen AR, Bjerkedal T: Fibromyalgia - A new cause for disability pension. Scand J Soc Med 1993;21:116-9.
8. Moldofsky H, Wong MTH, Lue FA: Litigation, sleep, symptoms and disabilities in postaccident pain (fibromyalgia). J Rheumatol 1993;20:1935-40.
9. Reilly PA Fibromyalgia in the workplace - A management problem Ann Rheum Dis 1993,52:249-51.
10. Wolfe F: Disability and the dimensions of distress in fibromyalgia. J Musc Pain 1993;1:65-88.
11. Greenfield S, Fitzcharles MA, Esdaile JM: Reactive fibromyalgia syndrome. Arthritis Rheum 1992;35:678-81.
12. Potter JW: Helping fibromyalgia patients obtain social security benefits. J Musculo Med 1992;9:65-74.
13. Whorton D, Weisenberger BI, Milroy WC, et al. Does fibromyalgia qualify as a work-related illness or injury. J Occup Med 1992;34:968-70.
14. Cathey MA, Wolfe F, Roberts FK, et al.: Demographic, work disability, service utilization and treatment characteristics of 620 fibromyalgia patients in rheumatologic practice (abstr). Arthritis Rheum 1990;(suppl)33:S10.
15. Romano TJ Clinical experiences with post-traumatic fibromyalgia syndrome. W V Med J 1990;86:198-202.
16. Littlejohn GO: Medicolegal aspects of fibrositis syndrome. J Rheumatol 1989;(suppl 19)16:169-73.
17. Littlejohn GO: Fibrositis/fibromyalgia syndrome in the workplace. Rheum Dis Clin North Am 1989;15:45-60.
18. McCain GA, Cameron R, Kennedy JC: The problem of longterm disability payments and litigation in primary fibromyalgia. The Canadian perspective. J Rheumatol 1989;(suppl 19)16.174-6.
19. Saskin P, Moldofsky H, Lue FA: Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome). Psychosom Med 1986;48:319-23.
20. Wolfe F: Post-traumatic fibromyalgia: A case report narrated by the patient. Arthritis Care Res 1994;7:161-5.
21. Kramer MS, Lane DA. Causal propositions in clinical research and practice. J Clin Epidemiol 1992;45:639-49
22. Wilke WS, Sheeler LR, Makarowski WS: Hypothyroidism with presenting symptoms of fibrositis. J Rheumatol 1981;8:626-31.
23. Carette S, Lefrancois L: Fibrositis and primary hypothyroidism. J Rheumatol 1988;15:1418-21.
24. Moldofsky H: Fibromyalgia. sleep disorder and chronic fatigue syndrome. In. Block GR, Whelan J, eds. Chronic Fatigue Syndrome. Chichester: Wiley. 1993.262-79.
25. Moldofsky H, Lue FA: Sleep and symptoms in 205 fibromyalgia patients vs 876 patients with various sleep disorders (abstr). Sleep Res 1992;2:303.
26. Arroyo JF, Cohen ML: Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 1993;20:1925-31
27. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC: Plasma tryptophan and other amino acids in primary fibromyalgia - A controlled study. J Rheumatol 1992;19:90-4
28. Stratz T, Samborski W, Hrycaj P, et al.: Serum serotonin concentrations in patients with generalized tendomyopathy (fibromyalgia) and rheumatoid arthritis. Med Klin 1993;88:458-62.
29. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA: Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992;19:104-9.
30. Bennett RM, Clark SR, Campbell SM, Burckhardt CS: Low levels of somatomedin C in patients with the fibromyalgia syndrome - A possible link between sleep and muscle pain. Arthritis Rheum 1992,35:1113-6
31. Vaeroy H, Helle R, Forro O, Kass E, Terenius L: Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia. New features for diagnosis. Pain 1988;32:21-6.
32. Griep EN, Boersma JW, Dekloet ER: Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993;20:469-74.
33. Caro XJ: Immunofluorescent detection of IgG at the dermal-epidermal junction in patients with apparent primary fibrositis syndrome. Arthritis Rheum 1984;27.1174-9.
34. Wallace DJ, Bowman RL, Wormsley SB, Peter JB: Cytokines and immune regulation in patients with fibrositis (letter). Arthritis Rheum 1989;32:1334-5; 1607 (erratum).
35. Jacobsen S, Höyer-Madsen M, Danneskiold-Samsoe B, Wiik A. Screening for autoantibodies in patients with primary fibromyalgia syndrome and a matched control group. APMIS 1990;98:655-8.
36. Dinerman H, Goldenberg DL, Felson DT: A prospective evaluation of 118 patients with the fibromyalgia syndrome: Prevalence of Raynaud's phenomenon, sicca symptoms. ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 1986,13.368-73.
37. Hawley DJ, Wolfe F: Pain, disability, and pain/disability relationships in seven rheumatic disorders: A study of 1522 patients. J Rheumatol 1991;18:1552-7.
38. Cathey MA, Wolfe F, Kleinheksel SM, Miller S, Pitetti KH: Functional ability and work status in patients with fibromyalgia. Arthritis Care Res 1988;1:85-98.
39. Jacobsen S, Holm B: Muscle strength and endurance compared to aerobic capacity in primary fibromyalgia syndrome. Clin Exp Rheumatol 1992;10:419-20.
40. Mengshoel AM, Komnaes HB, Forre O: The effects of 20 weeks of physical fitness training in female patients with fibromyalgia Clin Exp Rheumatol 1992;10:345-9.
41. 133xenon clearance from exercising muscle. Arthritis Rheum 1989,32:454-60.
42. Jacobsen S, Danneskiold-Samsoe B: Isometric and isokinetic muscle strength in patients with fibrositis syndrome. New characteristics for a difficult definable category of patients. Scand J Rheumatol 1987;16:61-5.
43. Smythe HA, Buskila D, Gladman DD: Performance of scored palpation, a point count, and dolorimetry in assessing unsuspected nonarticular tenderness. J Rheumatol 1993;20:352-1.
44. Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 1991;18:728-33.
45. Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A: A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994;21:714-20
46. Wolfe F: Data collection and utilization: A methodology for clinical practice and clinical research. In: Wolfe F, Pincus T, eds Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. New York: Marcel Dekker, 1994:463-514
47. Callahan LF, Smith WJ, Pincus T: Self report questionnaires in five rheumatic diseases: Comparisons of health status constructs and associations with formal education level. Arthritis Care Res 1989,2:122-31.
48. Henriksson CM: Longterm effects of fibromyalgia on everyday life A study of 56 patients. Scand J Rheumatol 1994;23:36-41
49. Hidding A, Vansanten M, Deklerk E, et al.: Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol 1994,21:818-23.
50. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA: A comparison of cyclobenzaprine and placebo in the management of fibrositis: A double-blind controlled study. Arthritis Rheum 1988,31:1535-42.
51. Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum 1986;29:655-9.
52. Goldenberg DL, Felson DT, Dinerman H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986;29:1311-7.
53. Jaeschke R, Adachi JD, Guyatt G, Keller J, Wong B: Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized controlled trials. J Rheumatol 1991;18:447-51.
54. Carette S, Bell MJ, Reynolds WJ, et al.: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia - A randomized, double-blind clinical trial. Arthritis Rheum 1994;37:32-40.
55. Russell IJ, Fletcher EM, Michalek JE, Mcbroom PC, Hester GG: Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam - A double-blind, placebo-controlled study. Arthritis Rheum 1991;34:552-60.
56. McCain GA, Bell DA, Mai FM, Halliday PD: A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of fibromyalgia. Arthritis Rheum 1988;31:1135-41.
57. Yunus MB, Masi AT, Aldag JC: Short term effects of ibuprofen in primary fibromyalgia syndrome. A double blind, placebo controlled trial. J Rheumatol 1989;16.527-2, 855 (erratum).
58. Clark S, Tindall E, Bennett RM A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 1985;12:980-3.
59. Kaplan KH, Goldenberg DL, Galvinnadeau M: The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiat 1993;15:284-9.
60. Nelson WR, Walker C, McCain GA: Cognitive behavioral treatment of fibromyalgia syndrome. Preliminary finding. J Rheumatol 1992;19:98-103.
61. Bradley LA: Cognitive-behavioral therapy for primary fibromyalgia. J Rheumatol 1989;(suppl 19)16:131-6.
62. Burckhardt CS, Clark SR, Campbell SM, O'Reilly CA, Wiens AN, Bennett RM: Multidisciplinary treatment of fibromyalgia (abstr). Scand J Rheumatol 1992;(suppl)21:51.
63. Ledingham J, Doherty S, Doherty M: Primary fibromyalgia syndrome - An outcome study. Br J Rheumatol 1993;32:139-42.
64. Bruckle W, Muller W: Course and topography of pain in generalized fibromyalgia. Z Rheumatol 1991;50:19-28.
65. Hawley DJ, Wolfe F, Cathey MA: Pain, functional disability, and psychological status: A 12-month study of severity in fibromyalgia J Rheumatol 1988;15.1551-6.
66. Felson DT, Goldenberg DL: The natural history of fibromyalgia. Arthritis Rheum 1986;29.1522-6.
67. Granges G, Zilko P, Littlejohn GO: Fibromyalgia syndrome - Assessment of the severity of the condition 2 years after diagnosis. J Rheumatol 1994;21:523-9.
68. Bengtsson A, Henriksson KG, Jorfeldt L, Kagedal B, Lennmarken C, Lindstrom F: Primary fibromyalgia: A clinical and laboratory study of 55 patients. Scand J Rheumatol 1986;15:340-7.
69. Cathey MA, Wolfe F, Kleinheksel SM, Hawley DJ: Socioeconomic impact of fibrositis. A study of 81 patients with primary fibrositis. Am J Med 1986;81:78-84
70. Mason JH, Simms RW, Goldenberg DL, Meenan RF: The impact of fibromyalgia on work: A comparison with RA (abstr). Arthritis Rheum 1989;(suppl)32:S197.